Assessment of Spread of Transversus Abdominis Plane Block
NCT ID: NCT01024868
Last Updated: 2010-05-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study Investigating Properties of the Transversus Abdominis Plane Block
NCT01679392
Method Study: Bilateral TAP Block With 24 Hours Infusion
NCT01577940
Study to Determine if Pre- and Post- Operative TAP Catheters With Ropivacaine Versus Placebo Affects Anesthetic, Narcotic Dosing, and Pain Scores
NCT03149783
Local Infiltration Analgesia in Major Spine Surgery With Ropivacaine Versus Placebo
NCT00771459
The Effect of Local Anaesthetic Volume on Nerve Block Duration and Nerve Block Duration Variability
NCT02829697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TAP block
Patients before undergoing laparoscopic or other abdominal surgery
Ropivacaine 0,5%
Injection of ropivacaine 0,5% 20 ml bilaterally before surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine 0,5%
Injection of ropivacaine 0,5% 20 ml bilaterally before surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glostrup University Hospital, Copenhagen
OTHER
Herlev Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Herlev University Hospital, Copenhagen
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ann M Møller, dr. med.
Role: STUDY_DIRECTOR
Herlev Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herlev University Hospital
Herlev, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Torup H, Mitchell AU, Breindahl T, Hansen EG, Rosenberg J, Moller AM. Potentially toxic concentrations in blood of total ropivacaine after bilateral transversus abdominis plane blocks; a pharmacokinetic study. Eur J Anaesthesiol. 2012 May;29(5):235-8. doi: 10.1097/EJA.0b013e328350b0d5.
Mitchell AU, Torup H, Hansen EG, Petersen PL, Mathiesen O, Dahl JB, Rosenberg J, Moller AM. Effective dermatomal blockade after subcostal transversus abdominis plane block. Dan Med J. 2012 Mar;59(3):A4404.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TDTSG-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.